Home Search

eoe - search results

If you're not happy with the results, please do another search

End Allergies Together Funds EoE Diagnostic Research

0
EoE is on the rise and may increase even more once oral immunotherapy becomes commonplace. EAT is funding research into a better diagnostic.

Risk of EoE to Those That Have Outgrown Allergy to Same Food

0
A study asserts that individuals who have outgrown a food allergy may be at risk of developing eosinophilic esophagitis to the same food.
Gut Barrier Defect Peanut Allergy

Study Finds Gut Barrier Defects May Predispose People to Peanut Allergy

0
Study links peanut allergy susceptibility to pre-existing intestinal barrier defects, Paneth cell dysfunction, and loss of protective lysozyme.
Dupixent (dupilumab) Increases Reactions

Study Finds Eczema Drug Dupilumab Drives Down Food Allergy IgE but Increases Reactions

0
Dupilumab dramatically lowers food-specific IgE, but new research finds those declines may not signal increased food tolerance.
FAF Research

Breakthroughs on the Horizon: FAF Funds Five New Studies Targeting Food Allergies

0
Food Allergy Fund is backing five innovative studies exploring AI, immune pathways, nutrition, and microbiome-based approaches to food allergy.
Hope

Hope on the Horizon: Ten Food Allergy Research Breakthroughs in 2025

0
Explore the latest breakthroughs in food allergy research from 2025 that aim to prevent anaphylaxis and promote long-term immunity.
Clinical Study

FAF Funding Four New Food Allergy Research Projects Working Toward Finding Treatments and a...

0
Working toward treatments and a cure for food allergies.
Ilana Golant Interview

A Conversation About the Food Allergy Fund and Breakthroughs on the Horizon

0
Be astonished by the advances in treatment going on behind the scenes!
Dupixent (dupilumab)

Dupilumab Lowered IgE Levels in Small Study

0
Promise for another possible treatment for food allergy.
AAAAI Omalizumab

Omalizumab (Xolair) Is Superior to Oral Immunotherapy in Multi-Food Allergy Treatment

0
Research finds food allergic patients have better outcomes with omalizumab than oral immunotherapy.

Follow Us

51,241FansLike
12,815FollowersFollow
2,913FollowersFollow
620FollowersFollow
179SubscribersSubscribe